At Prima BioMed, a company manufacturing ovarian cancer vaccines at the Peter MacCallum Cancer Centre in Melbourne, blood samples arrive from around the world, are processed by highly trained scientists, and are exported to a worldwide market at a premium. Dozens of Australian start-ups - including Mesoblast and Acrux - are doing similar things, forming part of Australia's dynamic biotech cluster and showing leadership in advanced manufacturing
Read more: http://www.smh.com.au/opinion/politics/time-to-go-from-sticking-heads-in-the-ground-to-trying-new-ideas-20110926-1ktkm.html#ixzz1Z4OVpcfi
At Prima BioMed, a company manufacturing ovarian cancer vaccines...
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
28.0¢ |
Change
-0.005(1.75%) |
Mkt cap ! $406.7M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 29.0¢ | 27.5¢ | $1.341M | 4.777M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 167966 | 28.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.5¢ | 138542 | 5 |
View Market Depth
| Last trade - 16.10pm 04/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |